Effects of different routes of cyclosporin A administration on blood levels in patients undergoing bone marrow transplantation

Bone Marrow Transplantation

Volumn 19, Issue 4, 1997, Pages 369-372

  Capone, D ^a   De Marino, V ^a   Fontana, R ^b   Notaro, R ^b   Pisanti, N ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Farmacologia Policlinico   (Italy)

Author keywords

Bone marrow; Cyclosporin A; Transplantation

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BOLUS INJECTION; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG WITHDRAWAL; FEMALE; HUMAN; INTESTINE; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031058643     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700660     Document Type: Article

References (28)

1. Pappalettera M, Pizzi C, Cardillo M et al. Factors influencing cadaver kidney graft survival in two cyclosporine periods. Transplant Proc 1994; 26: 2533-2534.
2. Wauters JP, Rosman JB, Descombes E et al. Ten year experience with low-dose cyclosporin A in renal transplantation. Transplant Proc 1994; 26: 2528-2529.
3. Inoue S, Beck Y, Nagao T, Uchida H. Early fluctuation in cyclosporin A trough levels affects long-term outcome of kidney transplants. Transplant Proc 1994; 26: 2571-2573.
4. Gupta SK, Manfro RC, Tomlanovich SJ et al. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration. J Clin Pharmacol 1990; 30: 643-653.
5. Lindholm A. Factors influencing the pharmacokinetics of cyclosporine in man. Ther Drug Monit 1991; 13: 465-477.
6. Yee GC, McGuire TR, Gmur DJ et al. Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Transplantation 1988; 46: 399-402.
7. Browne BJ, Jordan S, Welsh MS et al. Diet and cyclosporin A pharmacokinetics comparison between Neoral and Sandimmune gelatine capsules. Transplant Proc 1994; 26: 2959-2960.
8. Wong PY, Mee AV, Glenn J, Keown PA. Performance of HPLC, Cyclotrac SP, TDx, and Syva whole blood cyclosporine assays in the Canadian quality assurance program. Transplant Proc 1994; 26: 2809-2810.
9. Dusci LJ, Hackett LP, Chiswell GM, Ilett KF. Comparison of cyclosporine measurement in whole blood by high-performance liquid chromotography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassay. Ther Drug Monit 1992; 14: 327-332.
10. Armijo JA, Navarro FA, De Cos MA. Is the monoclonal fluorescence polarization immunoassay for cyclosporine specific? Comparison with specific radioimmunoassay. Ther Drug Monit 1992; 14: 333-338.
11. Gupta SK, Benet LZ. HPLC measurement of cyclosporine in blood, plasma and urine and simultaneous measurement of its four metabolites in blood. J Liq Chromatogr 1988; 12: 1451-1462.
12. Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: identification of a cytochrome P450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988; 43: 630-635.
13. Combalbert J, Fabre I, Fabre G et al. Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P450 (cyclosporine A oxidase) as a product of P450IIIA gene subfamily. Drug Metab Dispos 1989; 17: 197-207.
14. Aoyama T, Yamano S, Waxman DJ et al. Cytochrome P-450hPCN3, a novel cytochrome P-450IIIA gene product that is differentially expressed in adult human liver. J Biol Chem 1989; 264: 10388-10395.
15. Kolars JC, Stetson PL, Rush BD et al. Cyclosporin A metabolism by P450IIIa in rat enterocytes - another determinant of oral bioavailability? Transplantation 1992; 53: 596-602.
16. Wenger RM. Structures of cyclosporine and its metabolites. Transplant Proc 1990; 22: 1104-1108.
17. Maurer G, Loosli R, Schreier E, Keller H. Disposition of cyclosporine in several animal species and man - structural elucidation of its metabolites. Drug Metab Dispos 1984; 12: 120-126.
18. Hartman NR, Trimble LA, Vegeras JC, Jardine I. An acid metabolite of cyclosporine. Biochem Biophys Res Commun 1986; 133: 964-971.
19. Hashem H,Venkataramanan R, Burchart G et al. Identification of the aldehyde metabolites. Transplant Proc 1988; 20: 176-178.
20. Meier PG, Park SG, Yee GC, Gmur DJ. Isolation and identification of a novel human metabolite of cyclosporin A: dihydro-CsA M17. Drug Metab Dispos 1990; 18: 68-72.
21. Christians U, Strohmeyer S, Kownatzki R et al. Investigations on the metabolic pathways of cyclosporine. I. Excretion of cyclosporine and its metabolites in human bile - isolation of 12 new cyclosporine metabolites. Xenobiotica 1991; 21: 1185-1198.
22. Sewing K-FR, Christians U, Kohlhaw K et al. Biologic activity of cyclosporine metabolites. Transplant Proc 1990; 22: 1129-1134.
23. Fahr A, Hiestand P, Ryffel B. Studies on the biologic activities of sandimmun metabolites in humans and in animal models: review and original experiments. Transplant Proc 1990; 22: 1116-1124.
24. Kahan BD. Pharmacokinetics and pharmacodynamics of cyclosporine. Transplant Proc 1989; 21 (Suppl. 1): 9-15.
25. Kivisto KT. A review of assay methods for cyclosporin. Clinical implications. Clin Pharmacokinet 1992; 23: 173-190.
26. Hoppu K, Koskimies O, Holmberg C, Hirvisalo EL. Evidence for pre-hepatic metabolism of oral cyclosporine in children. Br J Clin Pharm 1991; 32: 477-481.
27. Lindholm A, Napoli K, Rutzky L, Kahan BD. Specific monoclonal radioimmunoassay and fluroescence polarization immunoassay for trough concentration and area-under curve monitoring of cyclosporine in renal transplantation. Ther Drug Monit 1992; 14: 292-300.
28. Aweeka FT, Tomlanovich SJ, Prueksaritanont T et al. Pharmacokinetics of orally and intravenously administered cyclosporine in pre-kidney transplant patients. J Clin Pharmacol 1994; 34: 60-67.